SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Novo Nordisk
Novo Nordisk
Page 5 of 8
Health
A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
By
Naomi Kresge
and
Bloomberg
June 27, 2024
Health
EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
By
Naomi Kresge
and
Bloomberg
June 26, 2024
Tech
Novo Nordisk’s Wegovy may have just two years to take over China’s market for weight-loss drugs
By
Lionel Lim
June 26, 2024
Health
Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
By
Naomi Kresge
and
Bloomberg
June 25, 2024
Retail
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By
Ryan Hogg
June 17, 2024
Retail
Danish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 23, 2024
Retail
Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By
Sasha Rogelberg
May 21, 2024
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Retail
Bernie Sanders urges Danish pharma giant Novo Nordisk to lower its drug prices: ‘Help the American people’
By
Christian Wienberg
and
Bloomberg
May 13, 2024
Retail
People will keep eating Oreos despite Ozempic surge, according to CEO of maker, Mondelez
By
Deena Shanker
and
Bloomberg
May 3, 2024
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By
Naomi Kresge
and
Bloomberg
May 2, 2024
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 1, 2024
Health
No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
By
Jonel Aleccia
and
The Associated Press
April 13, 2024
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By
Ryan Hogg
April 10, 2024
Health
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
By
Naomi Kresge
and
Bloomberg
April 6, 2024
Most Popular
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg